Novel method for constructing nomogram of multiple myeloma
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI TISSUEBANK MEDICAL LAB CO LTD
- Publication Date
- 2019-09-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a multiple myeloma nomogram construction method based on ten gene characteristics, serum Ξ²2-microglobulin and LDH. Background technique
[0002] Multiple myeloma (MM) is a malignant plasma cell disease in which tumor cells originate from plasma cells in the bone marrow, which are cells that develop to the final functional stage of B lymphocytes. At present, the heterogeneity of multiple myeloma has been paid more and more attention. However, no effective and simple MM prognostic model has been established in the world. Contents of the invention
[0003] The present invention provides a multiple myeloma nomogram construction method based on ten gene characteristics, serum Ξ²2-microglobulin and LDH, which can effectively solve the above problems.
[0004] The present invention is achieved like this:
[0005] A method for constructing a multiple myeloma nomogram based on ten gene signatures, serum Ξ²2-microglobulin and LDH, comp...